Northwest Bioth Cmn (NWBO)

$0.29 -0.03 (-10.91%)
Market Cap 397.78M
Revenue (ttm) 1.38M
Net Income (ttm) -83.78M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -6,071.01%
Debt to Equity Ratio 0.00
Volume 9,496,054
Avg Vol 3,572,600
Day's Range N/A - N/A
Shares Out 1.56B
Stochastic %K 93%
Beta -0.86
Analysts Strong Buy
Price Target $2.00

Company Profile

Northwest Biotherapeutics, Inc., a biotechnology company, focuses on developing personalized immune therapies for cancer. The company develops DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product candidate is the DCVax-L, which has completed Phase III clinical trials to treat Glioblastoma multiforme brain cancer. The company also develops DCVax-Direct, that has completed Phase I clinical trials to treat inop...

Industry: Biotechnology
Sector: Healthcare
Phone: 240 497 9024
Address:
4800 Montgomery Lane, Suite 800, Bethesda, United States
pacislander
pacislander Jan. 6 at 9:18 PM
$NWBO I found this in investor hub. I believe it is not fake
1 · Reply
DeepThought
DeepThought Jan. 6 at 9:16 PM
$NWBO You are the biggest joke in this galaxy and by far the biggest psycho, someone who urgently needs medical help!
0 · Reply
shomecabbage
shomecabbage Jan. 6 at 9:15 PM
$NWBO This is the news on Nov 20, that was never posted on E*TRADE. It just doesn’t seem that they would go through all this if they were worried about approval. And why it did not make it on E*TRADE. I have no idea!
0 · Reply
808right
808right Jan. 6 at 9:09 PM
$NWBO @sandhu5959 That might be part of it but it’s unlikely. First of all, you can’t just sell in 2025 and then buy back in a few days in 2026, as tax loss harvesting requires that you do NOT re-purchase shares for at least 31 days. So in order for what you are saying to be the cause, everyone would’ve had to sell their shares in late November in order to be able to buy back all at once in early January. The NEWS that caused this spike is more likely the FACT that we discovered via the commission on human medicine CHM meeting minutes that DCVAX was reviewed for approval on November 28, 2025. Based on that fact, approval could come any day. Don’t be surprised if we get one or two more down days, followed by another massive rally late this week into next week as people buy in anticipation of approval and the short sellers begin to lose their DEATH GRIP on the share price… STAY TUNED!
0 · Reply
pacislander
pacislander Jan. 6 at 8:56 PM
$NWBO Page 3: What this means specifically for DCVax-L Given: Positive CHM advice on November 28, 2025 Late-stage review No major unresolved safety concerns ➡️ Approval is now a matter of “when,” not “if,” barring something truly unexpected. A reasonable expectation would be: Early to mid-December at the earliest By January still well within normal regulatory behavior Bottom line (plain English) Positive CHM advice = green light from experts MHRA usually approves within weeks, not months, after this point Remaining steps are administrative, not judgment calls ** Disclaimer ** Information by ChatGPT
0 · Reply
pacislander
pacislander Jan. 6 at 8:54 PM
$NWBO Page 2: How long after positive CHM advice does MHRA usually approve? There is no legally fixed number of days, but based on MHRA practice and past approvals, here’s the realistic range: ⏱ Typical timing after positive CHM advice - Fast cases: ~1–2 weeks - Common range: 2–6 weeks - Longer end (still normal): up to ~8 weeks When advice is clearly positive and no further questions are outstanding, approvals often come quite quickly. Why it can still take a few weeks: - Final wording of the Marketing Authorisation - Manufacturing / labeling confirmations - Internal MHRA sign-off and publication timing These are procedural, not scientific delays.
0 · Reply
pacislander
pacislander Jan. 6 at 8:51 PM
$NWBO Page 1: What positive CHM advice means When the CHM (Commission on Human Medicines) gives positive advice to the MHRA, it means: Independent UK experts have reviewed the safety, efficacy, and benefit–risk balance of DCVax-L They have concluded that the data supports approval At this stage, there are no major scientific objections left This is one of the last and most important hurdles in the UK approval process. The MHRA almost always follows positive CHM advice unless there is an exceptional administrative or legal issue (which is rare). In short: 👉 Scientifically, DCVax-L has cleared the bar. What remains is mainly regulatory finalization, not debate.
2 · Reply
ImmxBeliever
ImmxBeliever Jan. 6 at 8:44 PM
$NWBO I want real clear why I shorted this stock this morning only one person made me do it and it was @DeepThought That guy is the second biggest clown after the Danish boy Keep it coming deep thought I own you  
0 · Reply
Dpveshn
Dpveshn Jan. 6 at 8:39 PM
$NWBO … it is not the bears … it is the greed of some bulls …. it is a fact of life ……. until the approval.
1 · Reply
broken_zamboni
broken_zamboni Jan. 6 at 8:36 PM
$NWBO what a tepid bowl of dong water this pump turned out to be. Seriously, how many times do you guys need to blueball yourselves?
0 · Reply
Latest News on NWBO
No data available.
pacislander
pacislander Jan. 6 at 9:18 PM
$NWBO I found this in investor hub. I believe it is not fake
1 · Reply
DeepThought
DeepThought Jan. 6 at 9:16 PM
$NWBO You are the biggest joke in this galaxy and by far the biggest psycho, someone who urgently needs medical help!
0 · Reply
shomecabbage
shomecabbage Jan. 6 at 9:15 PM
$NWBO This is the news on Nov 20, that was never posted on E*TRADE. It just doesn’t seem that they would go through all this if they were worried about approval. And why it did not make it on E*TRADE. I have no idea!
0 · Reply
808right
808right Jan. 6 at 9:09 PM
$NWBO @sandhu5959 That might be part of it but it’s unlikely. First of all, you can’t just sell in 2025 and then buy back in a few days in 2026, as tax loss harvesting requires that you do NOT re-purchase shares for at least 31 days. So in order for what you are saying to be the cause, everyone would’ve had to sell their shares in late November in order to be able to buy back all at once in early January. The NEWS that caused this spike is more likely the FACT that we discovered via the commission on human medicine CHM meeting minutes that DCVAX was reviewed for approval on November 28, 2025. Based on that fact, approval could come any day. Don’t be surprised if we get one or two more down days, followed by another massive rally late this week into next week as people buy in anticipation of approval and the short sellers begin to lose their DEATH GRIP on the share price… STAY TUNED!
0 · Reply
pacislander
pacislander Jan. 6 at 8:56 PM
$NWBO Page 3: What this means specifically for DCVax-L Given: Positive CHM advice on November 28, 2025 Late-stage review No major unresolved safety concerns ➡️ Approval is now a matter of “when,” not “if,” barring something truly unexpected. A reasonable expectation would be: Early to mid-December at the earliest By January still well within normal regulatory behavior Bottom line (plain English) Positive CHM advice = green light from experts MHRA usually approves within weeks, not months, after this point Remaining steps are administrative, not judgment calls ** Disclaimer ** Information by ChatGPT
0 · Reply
pacislander
pacislander Jan. 6 at 8:54 PM
$NWBO Page 2: How long after positive CHM advice does MHRA usually approve? There is no legally fixed number of days, but based on MHRA practice and past approvals, here’s the realistic range: ⏱ Typical timing after positive CHM advice - Fast cases: ~1–2 weeks - Common range: 2–6 weeks - Longer end (still normal): up to ~8 weeks When advice is clearly positive and no further questions are outstanding, approvals often come quite quickly. Why it can still take a few weeks: - Final wording of the Marketing Authorisation - Manufacturing / labeling confirmations - Internal MHRA sign-off and publication timing These are procedural, not scientific delays.
0 · Reply
pacislander
pacislander Jan. 6 at 8:51 PM
$NWBO Page 1: What positive CHM advice means When the CHM (Commission on Human Medicines) gives positive advice to the MHRA, it means: Independent UK experts have reviewed the safety, efficacy, and benefit–risk balance of DCVax-L They have concluded that the data supports approval At this stage, there are no major scientific objections left This is one of the last and most important hurdles in the UK approval process. The MHRA almost always follows positive CHM advice unless there is an exceptional administrative or legal issue (which is rare). In short: 👉 Scientifically, DCVax-L has cleared the bar. What remains is mainly regulatory finalization, not debate.
2 · Reply
ImmxBeliever
ImmxBeliever Jan. 6 at 8:44 PM
$NWBO I want real clear why I shorted this stock this morning only one person made me do it and it was @DeepThought That guy is the second biggest clown after the Danish boy Keep it coming deep thought I own you  
0 · Reply
Dpveshn
Dpveshn Jan. 6 at 8:39 PM
$NWBO … it is not the bears … it is the greed of some bulls …. it is a fact of life ……. until the approval.
1 · Reply
broken_zamboni
broken_zamboni Jan. 6 at 8:36 PM
$NWBO what a tepid bowl of dong water this pump turned out to be. Seriously, how many times do you guys need to blueball yourselves?
0 · Reply
sonar2stock
sonar2stock Jan. 6 at 8:36 PM
$NWBO Lets see where this goes tomorrow, I got $700 to add.
0 · Reply
Micha3lJordan
Micha3lJordan Jan. 6 at 8:23 PM
$NWBO bears will be back tomorrow 👀
1 · Reply
Investor1862
Investor1862 Jan. 6 at 8:18 PM
$NWBO nice price increase and massive increase in market cap, price and movenents before approval isnt worth stressing over.
0 · Reply
ksparker2
ksparker2 Jan. 6 at 8:12 PM
$NWBO Their disregard for the law, the pending lawsuit, investors and most importantly cancer patients is really beyond words. Are we surprised by today? Not really. But the one thing that is different and almost certain is approval can happen any day. So cheers to the bulls. Justice will come and it will be painful for these filthy,soulless demons who walk amongst us.
0 · Reply
lowbecutos
lowbecutos Jan. 6 at 8:12 PM
$NWBO why the push up yesterday and today 11%?? Or no news?
1 · Reply
sDinvestments1
sDinvestments1 Jan. 6 at 8:06 PM
$NWBO 9 million shares traded with 55 mins left on the clock. Will it be a power hour or sour hour. Hoping for a late rally! GL
0 · Reply
Twister8
Twister8 Jan. 6 at 8:04 PM
$NWBO Q1 should show a sizeable increase in expenditures now that Advent is NWBO....
0 · Reply
ImmxBeliever
ImmxBeliever Jan. 6 at 8:02 PM
$NWBO Such an easy short
1 · Reply
Twister8
Twister8 Jan. 6 at 7:50 PM
$NWBO LOL!!! y'all know the drill...quit whining...
0 · Reply
JPD2213
JPD2213 Jan. 6 at 7:48 PM
$NWBO it’s the same story day after day, month after month, year after year. We get our hopes up for nothing. Such a joke!
1 · Reply
pacislander
pacislander Jan. 6 at 7:36 PM
$NWBO $300 buys you 1,000 shares today. Approval could turn that into $1,000–$2,000. Buy more get more 😄
1 · Reply
Kensfuqt
Kensfuqt Jan. 6 at 7:33 PM
$NWBO Crime is all they got hopefully the Judge is taking notes.
1 · Reply